4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-015778
President and CEO sold 450,000 shares at $2.87 ($1,291,500)
- President and CEO acquired 315,450 shares (option exercise)
- President and CEO gave up 5,343 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Culley Brian M · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-28 | Exercise or conversion : show line 1 in the form | +300,000 | $0.69 | $207,570 | 495,709 | D |
| 2021-06-28 | Sale : show line 2 in the form | −450,000 | $2.87 | $1,291,500 | 45,709 | D |
| 2021-06-30 | Exercise or conversion : show line 3 in the form | +15,450 | $2.85 | $44,033 | 61,159 | D |
| 2021-06-30 | Shares withheld for taxes : show line 4 in the form | −5,343 | $2.85 | $15,228 | 55,816 | D |
| Open-market sales · 450,000 sh · avg $2.87 · $1,291,500 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-28 | Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) | −300,000 | 933,300 | D |
| 2021-06-30 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −15,450 | 61,800 | D |
Loading xslF345X03/ownership.xml…